Advertisement
Advertisement
SXTP
60 Degrees Pharmaceuticals, Inc. Common Stock
1.96
USDSponsored
-0.26
-11.71%
Apr 15, 16:00 UTC -4
Closed
After-Market
1.94
-0.02
-1.28%
SXTP Earnings Reports
Positive Surprise Ratio
SXTP beat 2 of 10 last estimates.
20%
Next Report
Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q-- -- (Revenue/ EPS)
--
/--
60 Degrees Pharmaceuticals, Inc. Common Stock earnings per share and revenue
On Mar 30, 2026, SXTP reported earnings of -2.34 USD per share (EPS) for Q4 25, missing the estimate of -2.32 USD, resulting in a -0.62% surprise. Revenue reached 303.00 thousand, compared to an expected 545.70 thousand, with a -44.47% difference. The market reacted with a +15.89% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Traws Pharma, Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$1.24
Actual
-$0.71
Surprise
+43.13%
Cosmos Holdings Inc. Common Stock
Report Date
Apr 15, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.14
Surprise
-243.14%
BIOMERICA INC
Report Date
Apr 13, 2026 For Q3 26
Estimate
-Actual
-$0.44
Surprise
-
Evotec SE - ADR
Report Date
Apr 08, 2026 For Q4 25
Estimate
$0.31
Actual
$0.08
Surprise
-74.45%
FAQ
What were 60 Degrees Pharmaceuticals, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, 60 Degrees Pharmaceuticals, Inc. Common Stock reported EPS of -$2.34, missing estimates by -0.62%, and revenue of $303.00K, -44.47% below expectations.
How did the market react to 60 Degrees Pharmaceuticals, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 15.89%, changed from $1.51 before the earnings release to $1.75 the day after.
When is 60 Degrees Pharmaceuticals, Inc. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for 60 Degrees Pharmaceuticals, Inc. Common Stock's next earnings report?
Based on --
analysts, 60 Degrees Pharmaceuticals, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement